ECM Partners Inc. appoints Peter Prock as Chairman of FAMAR Group Board of Directors

ECM Partners Inc., FAMAR’s major shareholder, announced today that Peter Prock is appointed as the new Chairman of the Board of Directors of FAMAR Group, a leading European contract development and manufacturing organization.

“I am delighted to be joining FAMAR as Chairman at such an exciting time for the company. FAMAR is an established player in the European CDMO sector and is known for its broad range of manufacturing capabilities, innovation, and its commitment to quality and to customers. I look forward to working closely with the board and management as we execute on our strategic growth plans” said Peter Prock.
Peter Prock is a widely respected executive, who has held various management roles in the pharmaceutical sector. Prior to forming Albrecht, Prock & Partners in 2016, Peter was CEO of Polpharma Group from 2013 to 2015, Deputy CEO of Actavis and CFO of Ratiopharm Group before its acquisition by Teva. Peter started his career at Sandoz, where he held various positions in Austria, Spain, the USA, and Germany. He is a board member of several pharmaceutical companies.

“We are delighted to have Peter lead the FAMAR board. Peter has an outstanding reputation in the industry and will play an important role in driving growth and value creation for all stakeholders,” said Savvas Liasis, ECM Partners Inc Chairman and Co-Managing Partner.